A prospective evaluation of nesiritide in the treatment of pediatric heart failure

Pediatric Cardiology

Volumn 27, Issue 4, 2006, Pages 402-407

  Jefferies, J L ^a,b   Denfield, S W ^a   Price, J F ^a   Dreyer, W J ^a   McMahon, C J ^a   Grenier, M A ^a   Kim, J J ^a   Dimas, V V ^a   Clunie, S K ^a   Moffett, B S ^a   Chang, A C ^a   Wann, T I ^a   Smith, E O ^a   Towbin, J A ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Heart failure; Natriuretic peptides; Pediatrics

Indexed keywords

ADRENALIN; AMLODIPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE; ELECTROLYTE; ETACRYNIC ACID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; MILRINONE; NESIRITIDE; OXYGEN; SPIRONOLACTONE; STATINE DERIVATIVE; STEROID; VASOACTIVE AGENT; VASOPRESSIN;

ADOLESCENT; ADULT; ARTICLE; CENTRAL VENOUS PRESSURE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; EVALUATION; FEMALE; FUNCTIONAL ASSESSMENT; HEART ARRHYTHMIA; HEART FAILURE; HEMODYNAMICS; HUMAN; HYPOTENSION; INFANT; INTENSIVE CARE UNIT; MALE; PATIENT MONITORING; PRESCHOOL CHILD; PROSPECTIVE STUDY; SCHOOL CHILD; SYMPTOMATOLOGY; THIRST; TREATMENT OUTCOME; URINE VOLUME;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD UREA NITROGEN; CHILD; CHILD, PRESCHOOL; CREATININE; ELECTROLYTES; FEMALE; HEART FAILURE; HEART FAILURE, CONGESTIVE; HEART RATE; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; NATRIURETIC AGENTS; NATRIURETIC PEPTIDE, BRAIN; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 33747113389     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-1294-8     Document Type: Article

References (24)

1. Abraham WT, Lowes BD, Ferguson DA, et al. (1998) Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 4:37-44
2. Boucek MM, Edwards LB, Keck BM, et al. (2003) The Registry of the International Society for Heart and Lung Transplantation: Sixth Official Pediatric Report - 2003. J Heart Lung Transplant 22:636-652
3. Brunner-La Rocca HP, Kaye DM, Woods RL, Hastings J, Esler MD (2001) Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 37:1221-1227
4. Chang R, Elatre WA, Heywood JT (2004) Effect of nesiritide on length of hospital stay in patients with decompensated heart failure. J Cardiovasc Pharmacol Ther 9:173-177
5. Colucci WS, Elkayam U, Horton DP, et al. (2000) Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 343:246-253
6. de Lissovoy G, Stier DM, Ciesla G, Munger M, Burger AJ (2003) Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure. Am J Cardiol 92:631-633
7. Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW (2000) The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35:681-689
8. Feingold B, Law YM (2004) Nesiritide use in pediatric patients with congestive heart failure. J Heart Lung Transplant 23:1455-1459
9. Hillege HL, Girbes AR, de Kam PJ, et al. (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102:203-210
10. Lenz TL, Foral PA, Malesker MA, Hunter CB, Hilleman DE (2004) Impact of nesiritide on health care resource utilization and complications in patients with decompensated heart failure. Pharmacotherapy 24:1137-1146
11. Lipshultz SE, Sleeper LA, Towbin JA, et al. (2003) The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 348:1647-1655
12. Marshall J, Berkenbosch JW, Russo P, Tobias JD (2004) Preliminary experience with nesiritide in the pediatric population. J Intensive Care Med 19:164-170
13. Mills RM, LeJemtel TH, Horton et al. (1999) Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group. J Am Coll Cardiol 34:155-162
14. Protter AA, Wallace AM, Ferraris VA, Weishaar RE (1996) Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens 9:432-436
15. Publication Committee for the VMAC Investigators (Vasodilation in the Management of Acute CHF) (2002) Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. J Am Med Assoc 287:1531-1540. [Erratum in: J Am Med Assoc 2002;288:577]
16. Rosenthal D, Chrisant MR, Edens E, et al. (2002) International Society for Heart and Lung Transplantation: practice guidelines for management of heart failure in children. J Heart Lung Transplant 23:1313-1333
17. Sackner-Bernstein JD, Skopicki HA, Aaronson KD (2005) Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111:1487-1491
18. Silver MA, Horton DP, Ghali JK, Elkayam U (2002) Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol 39:798-803
19. Smull DL, Jorde UP (2005) Concomitant use of nesiritide and milrinone in decompensated congestive heart failure. Am J Health Syst Pharm 62:291-295
20. Topol EJ (2005) Nesiritide - not verified. N Engl J Med 353:113-116
21. Wang DJ, Dowling TC, Meadows D, et al. (2004) Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 110:1620-1625
22. Yamamoto K, Burnett JC Jr, Redfield MM (1997) Effect of endogenous natriuretic peptide system on ventricular and coronary function in failing heart. Am J Physiol 273:H2406-H2414
23. Yasue H, Yoshimura M (1996) Natriuretic peptides in the treatment of heart failure. J Card Fail 2(Suppl):S227-S285
24. Yoshimura M, Yasue H, Morita E, et al. (1991) Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84:1581-1588